A next-generation metagenomic sequencing test developed at UCSF demonstrates its ability to rapidly and accurately diagnose a ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

Perspectum, a leader in medical imaging quantification techniques, today announced that it has been awarded a 2024 U.S. Food and Drug Administration Drug Development Tool (DDT) Research Grant to ...

"These updates reflect the changing landscape of public health ... critical than ever," writing group co-chair Dr. Elizabeth ...

For pulmonologists and their patients, increased rates of wildfire raise questions about how best to avoid wildfire smoke ...

In an emerging red flag for the digital era, sleep experts have warned us to avoid screen time ... and medicine to address pressing issues like light pollution and its impact on pollinator health. Our ...

A new study links satellite data with brain imaging to reveal how environmental factors like light pollution, green spaces, ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.

The detailed structure of a misfolded protein from a diseased deer could help explain why the disease hasn’t made the leap to humans.